KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 126 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,140 | +23.4% | 65,607 | -0.1% | 0.48% | +30.4% |
| Q2 2023 | $924 | +39.4% | 65,654 | +6.6% | 0.37% | +32.7% |
| Q1 2023 | $663 | -28.2% | 61,599 | -0.0% | 0.28% | -32.2% |
| Q4 2022 | $923 | -99.9% | 61,609 | -24.9% | 0.41% | +37.6% |
| Q1 2022 | $815,000 | -10.1% | 81,995 | +6.4% | 0.30% | -8.0% |
| Q4 2021 | $907,000 | – | 77,069 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |